{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:36:43Z","timestamp":1793407003264,"version":"4.5.0"},"reference-count":127,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.ejca.2006.01.065","type":"journal-article","created":{"date-parts":[[2006,7,26]],"date-time":"2006-07-26T13:19:47Z","timestamp":1153919987000},"page":"1671-1683","source":"Crossref","is-referenced-by-count":49,"title":["Epidemiology and outcomes research for MGUS, myeloma and amyloidosis"],"prefix":"10.1016","volume":"42","author":[{"given":"Bhawna","family":"Sirohi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Powles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2006.01.065_bib1","first-page":"934a","article-title":"Prevalence of monoclonal gammopathy of undetermined significance (MGUS) among Olmsted County, MN residents 50 years of age","volume":"102","author":"Kyle","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2006.01.065_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/jcp.35.1.63","article-title":"Monoclonal gammopathies in the adult population of Finistere, France","volume":"35","author":"Saleun","year":"1982","journal-title":"J Clin Path"},{"key":"10.1016\/j.ejca.2006.01.065_bib3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.0954-6820.1966.tb05453.x","article-title":"Frequency of pathological proteins (M components) in 6,995 sera from an adult population","volume":"179","author":"Axelsson","year":"1966","journal-title":"Acta Medica Scandinavica"},{"key":"10.1016\/j.ejca.2006.01.065_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2141.1992.tb08245.x","article-title":"Malignant transformation and life expectancy in monoclonal gammopathy of undertermined significance","volume":"81","author":"Blade","year":"1992","journal-title":"B J Haematol"},{"key":"10.1016\/j.ejca.2006.01.065_bib5","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis of monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ejca.2006.01.065_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00277-004-0939-7","article-title":"Epidemiology of non-Hodgkin\u2019s lymphoma (NHL): trends, geographic distribution, and etiology","volume":"84","author":"Muller","year":"2005","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ejca.2006.01.065_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V91.1.3","article-title":"Multiple myeloma: increasing evidence for a multistep transformation process","volume":"91","author":"Hallek","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2006.01.065_bib8","unstructured":"Young JL, Percy CL, Asire AJ. Surveillance, epidemiology and end-results. Natl Cancer Institute Monograph 1981; 57. Bethseda: US Department of Health and Human Services."},{"key":"10.1016\/j.ejca.2006.01.065_bib9","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1001\/archinte.1996.00440120125014","article-title":"Multiple myeloma in patients younger than 30 years. Report of 10 cases and review of the literature","volume":"156","author":"Blade","year":"1996","journal-title":"Arch Int Med"},{"key":"10.1016\/j.ejca.2006.01.065_bib10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3109\/10428199809057562","article-title":"Multiple myeloma in young patients: clinical presentation and treatment approach","volume":"30","author":"Blade","year":"1998","journal-title":"Leukemia and Lymphoma"},{"key":"10.1016\/j.ejca.2006.01.065_bib11","series-title":"Myeloma","first-page":"139","article-title":"Epidemiology of plasma cell disorders","author":"Joshua","year":"2002"},{"key":"10.1016\/j.ejca.2006.01.065_bib12","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1182\/blood.V40.5.719.719","article-title":"Incidence of monoclonal proteins in a Minnesota community with a cluster of multiple myeloma","volume":"40","author":"Kyle","year":"1972","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2006.01.065_bib13","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/ijc.2910460435","article-title":"Trends in multiple myeloma (letter)","volume":"46","author":"Levi","year":"1990","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2006.01.065_bib14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-0609.1989.tb00250.x","article-title":"Trends in the incidence of multiple myeloma in Denmark 1943\u20131982: a study of 5500 patients","volume":"41","author":"Hansen","year":"1989","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ejca.2006.01.065_bib15","first-page":"701","article-title":"Cancer incidence and mortality trends among Whites in the United States 1947\u201384","volume":"79","author":"Devesa","year":"1987","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2006.01.065_bib16","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJM198402163100703","article-title":"Comparison of trends in the incidence of multiple myeloma in Malmo, Sweden, and other countries 1950\u20131979","volume":"310","author":"Turesson","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2006.01.065_bib17","unstructured":"Ries LAG, Eisner MP, Kosary CL, et al. (editors). SEER cancer statistics review, 1975\u20132002. Bethesda, MD: National Cancer Institute. Available from: http:\/\/seer.cancer.gov\/csr\/1975_2002\/ [based on November 2004 SEER data submission, posted to the SEER web site 2005]."},{"issue":"11","key":"10.1016\/j.ejca.2006.01.065_bib18","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/jnci\/93.11.824","article-title":"Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends","volume":"93","author":"Howe","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2006.01.065_bib19","series-title":"EUCAN: cancer incidence, mortality and prevalence in the European Union 1998, version 5.0. IARC CancerBase No.4.","author":"Ferlay","year":"1999"},{"key":"10.1016\/j.ejca.2006.01.065_bib20","series-title":"Myeloma: biology and management","year":"2004"},{"key":"10.1016\/j.ejca.2006.01.065_bib21","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2307\/3577495","article-title":"Studies of the mortality of A-bomb survivors. Mortality, 1950\u20131985: Part 2. Cancer mortality based on the recently revised doses (DS86)","volume":"121","author":"Shimizu","year":"1990","journal-title":"Radiat Res"},{"key":"10.1016\/j.ejca.2006.01.065_bib22","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.2307\/3578893","article-title":"Cancer incidence in atomic bomb survivors. Part III: Leukemia, lymphoma and multiple myeloma, 1950\u201387","volume":"137","author":"Preston","year":"1994","journal-title":"Radiat Res"},{"key":"10.1016\/j.ejca.2006.01.065_bib23","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/bjc.1989.99","article-title":"Geographical variation of mortality from leukemia and other cancers in England and Wales in relation to proximity to nuclear installations 1969\u201378","volume":"59","author":"Cook-Mozaffari","year":"1989","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2006.01.065_bib24","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/bmj.296.6618.332","article-title":"A summary of mortality and incidence of cancer in men from the United Kingdom who participated in the United Kingdom\u2019s atmospheric nuclear weapon tests and experimental programmes","volume":"296","author":"Darby","year":"1988","journal-title":"Br Med J Clin Res Ed"},{"key":"10.1016\/j.ejca.2006.01.065_bib25","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/jnci\/80.5.344","article-title":"Cancer among medical diagnostic x-ray workers in China","volume":"80","author":"Wang","year":"1988","journal-title":"JNCI"},{"key":"10.1016\/j.ejca.2006.01.065_bib26","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/bmj.304.6821.220","article-title":"Mortality and occupational exposure to radiation: first analysis of National Registry for Radiation Workers","volume":"304","author":"Kendall","year":"1992","journal-title":"BMJ"},{"key":"10.1016\/j.ejca.2006.01.065_bib27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2307\/3577633","article-title":"Analyses of combined mortality data on workers at the Hanford site, Oak Ridge National Laboratory, and Rocky Flats Nuclear Weapons Plant","volume":"120","author":"Gilbert","year":"1989","journal-title":"Radiat Res"},{"key":"10.1016\/j.ejca.2006.01.065_bib28","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1126\/science.142.3598.1492","article-title":"Leukemia, multiple myeloma, and aplastic anemia in American radiologists","volume":"142","author":"Lewis","year":"1963","journal-title":"Science"},{"key":"10.1016\/j.ejca.2006.01.065_bib29","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00004032-198906000-00005","article-title":"Cancer mortality around La Hague nuclear facilities","volume":"56","author":"Dousset","year":"1989","journal-title":"Health Physician"},{"key":"10.1016\/j.ejca.2006.01.065_bib30","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1136\/bmj.300.6733.1161","article-title":"Follow up of New Zealand participants in British atmospheric nuclear weapons tests in the Pacific","volume":"300","author":"Pearce","year":"1990","journal-title":"BMJ"},{"key":"10.1016\/j.ejca.2006.01.065_bib31","first-page":"323","article-title":"Multiple myeloma among atomic bomb survivors in Hiroshima and Nagasaki 1950\u201376: relationship to radiation dose absorbed by marrow","volume":"69","author":"Ichimaru","year":"1982","journal-title":"JNCI"},{"issue":"3","key":"10.1016\/j.ejca.2006.01.065_bib32","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2307\/3578221","article-title":"Monoclonal gammopathy in atomic bomb survivors","volume":"133","author":"Neriishi","year":"1993","journal-title":"Radiat Res"},{"key":"10.1016\/j.ejca.2006.01.065_bib33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0889-8588(18)30341-1","article-title":"The epidemiology of multiple myeloma","volume":"6","author":"Riedel","year":"1992","journal-title":"Hematol Oncol Clinics of N America"},{"issue":"5320","key":"10.1016\/j.ejca.2006.01.065_bib34","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1126\/science.276.5320.1851","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients","volume":"276","author":"Rettig","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ejca.2006.01.065_bib35","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0002-9343(85)90246-3","article-title":"Occurrence of malignant neoplasms in the Rochester, Minnesota, rheumatoid arthritis cohort","volume":"78","author":"Katusic","year":"1985","journal-title":"Am J Med"},{"key":"10.1016\/j.ejca.2006.01.065_bib36","first-page":"6916","article-title":"Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis","volume":"31","author":"Isomaki","year":"1978","journal-title":"J Chr Diseases"},{"key":"10.1016\/j.ejca.2006.01.065_bib37","first-page":"363","article-title":"Rheumatic autoantibodies in the sera of patients with paraproteins","volume":"12","author":"Hardiman","year":"1994","journal-title":"Clin and Exp Rheumatology"},{"key":"10.1016\/j.ejca.2006.01.065_bib38","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/bjc.1986.202","article-title":"Case-control study of multiple myeloma and farming","volume":"54","author":"Pearce","year":"1986","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2006.01.065_bib39","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ajim.4700140207","article-title":"Mortality among agricultural extension agents","volume":"14","author":"Alavanja","year":"1988","journal-title":"Am J Industr Med"},{"key":"10.1016\/j.ejca.2006.01.065_bib40","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/bjc.1989.290","article-title":"Occupation and lymphoid neoplasms","volume":"60","author":"La Vecchia","year":"1989","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2006.01.065_bib41","first-page":"95","article-title":"Occupational and other environmental factors and multiple myeloma: a population based case-control study","volume":"49","author":"Eriksson","year":"1992","journal-title":"Br J Industr Med"},{"issue":"1","key":"10.1016\/j.ejca.2006.01.065_bib42","first-page":"33","volume":"6","author":"Sonoda","year":"2005","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"10.1016\/j.ejca.2006.01.065_bib43","doi-asserted-by":"crossref","first-page":"215","DOI":"10.5271\/sjweh.782","volume":"30","author":"Baris","year":"2004","journal-title":"Scand J Work Environ Health"},{"key":"10.1016\/j.ejca.2006.01.065_bib44","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00001648-199309000-00004","article-title":"Cancer incidence in a population accidentally exposed to 2,3,7,8-tetrachlorodibenzo-para-dioxin","volume":"4","author":"Bertazzi","year":"1993","journal-title":"Epidemiology"},{"key":"10.1016\/j.ejca.2006.01.065_bib45","first-page":"1191","article-title":"Cancer mortality in metal workers","volume":"129","author":"Gallagher","year":"1983","journal-title":"Canadian Medical Association Journal"},{"key":"10.1016\/j.ejca.2006.01.065_bib46","first-page":"409","article-title":"Mortality experience of a cohort of rubber workers, 1964\u201373","volume":"20","author":"Andjelkovich","year":"1978","journal-title":"J Occup Med"},{"issue":"6","key":"10.1016\/j.ejca.2006.01.065_bib47","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/BF00052753","article-title":"Occupational risk factors for multiple myeloma among Danish men","volume":"3","author":"Heineman","year":"1992","journal-title":"Cancer Causes Control"},{"issue":"5","key":"10.1016\/j.ejca.2006.01.065_bib48","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/BF00051355","article-title":"Multiple myeloma among Danish women: employment history and workplace exposures","volume":"3","author":"Pottern","year":"1992","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ejca.2006.01.065_bib49","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/bjc.1988.118","article-title":"Multiple myeloma - a case-control study","volume":"57","author":"Cuzick","year":"1988","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2006.01.065_bib50","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM198704233161702","article-title":"Benzene and leukaemia. An epidemiologic risk assessment","volume":"316","author":"Rinsky","year":"1987","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ejca.2006.01.065_bib51","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1749-6632.1990.tb32070.x","article-title":"Is exposure to benzene a cause of human multiple myeloma?","volume":"609","author":"Goldstein","year":"1990","journal-title":"Ann NY Acad Sciences"},{"key":"10.1016\/j.ejca.2006.01.065_bib52","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/oem.52.6.380","article-title":"Risk of acute myeloid leukaemia and multiple myeloma in workers exposed to benzene","volume":"52","author":"Wong","year":"1995","journal-title":"Occup Environ Med"},{"issue":"Suppl 6","key":"10.1016\/j.ejca.2006.01.065_bib53","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1289\/ehp.961041393","article-title":"Does benzene cause multiple myeloma? An analysis of the published case-control literature","volume":"104","author":"Bezabeh","year":"1996","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.ejca.2006.01.065_bib54","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/jnci\/83.14.1036","article-title":"Cigarette smoking and risk of myeloma","volume":"83","author":"Brownson","year":"1991","journal-title":"JNCI"},{"key":"10.1016\/j.ejca.2006.01.065_bib55","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/0145-2126(92)90077-K","article-title":"Alcohol consumption and risk of leukemia, non-Hodgkin\u2019s lymphoma and multiple myeloma","volume":"16","author":"Brown","year":"1992","journal-title":"Leuk Res"},{"key":"10.1016\/j.ejca.2006.01.065_bib56","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/aje\/kwh041","article-title":"Association of obesity and cancer risk in Canada","volume":"159","author":"Pan","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ejca.2006.01.065_bib57","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.mehy.2005.05.014","article-title":"Association between obesity and ultiple myeloma in postmenopausal women may be attributed to increased aromatization of androgen in adipose tissue","volume":"65","author":"Islam","year":"2005","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.ejca.2006.01.065_bib58","series-title":"Cecil textbook of medicine","first-page":"1184","article-title":"Plasma cell disorders","author":"Kyle","year":"2004"},{"key":"10.1016\/j.ejca.2006.01.065_bib59","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group","volume":"121","author":"The International Myeloma Working Group","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejca.2006.01.065_bib60","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/sj.leu.2402183","article-title":"Thalidomide for previously untreated indolent or smoldering multiple myeloma","volume":"15","author":"Rajkumar","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.ejca.2006.01.065_bib61","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2141.1994.tb08304.x","article-title":"Bone marrow angiogenesis and progression in multiple myeloma","volume":"87","author":"Vacca","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejca.2006.01.065_bib62","first-page":"2210","article-title":"Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis","volume":"8","author":"Rajkumar","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2006.01.065_bib63","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1158\/0008-5472.CAN-03-2876","article-title":"Genetics and cytogenetics of multiple myeloma: a workshop report","volume":"64","author":"Fonseca","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejca.2006.01.065_bib64","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrc746","article-title":"Multiple myeloma: evolving genetic events and host interactions","volume":"2","author":"Kuehl","year":"2002","journal-title":"Nature Rev Cancer"},{"key":"10.1016\/j.ejca.2006.01.065_bib65","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.1038\/sj.onc.1204641","article-title":"Chromosome translocations in multiple myeloma","volume":"20","author":"Bergsagel","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.ejca.2006.01.065_bib66","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood.V100.4.1417.h81602001417_1417_1424","article-title":"Genomic abnormalities in monoclonal gammopathy of undetermined significance","volume":"100","author":"Fonseca","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2006.01.065_bib67","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1200\/JCO.20.6.1625","article-title":"Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma","volume":"20","author":"Cesana","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2006.01.065_bib68","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","article-title":"Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance (MGUS)","volume":"106","author":"Rajkumar","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2006.01.065_bib69","first-page":"717","article-title":"Management of multiple myeloma and related-disorders: guidelines from the Italian Society of Hematology (SIE), Italian Society of Experimental Hematology (SIES) and Italian Group for Bone Marrow Transplantation (GITMO)","volume":"89","author":"Barosi","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.ejca.2006.01.065_bib70","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/ki.1994.355","article-title":"Monoclonal immunoglobulin deposition disease (Randall type). Relationship with structural abnormalities of immunoglobulin chains","volume":"46","author":"Preud\u2019homme","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejca.2006.01.065_bib71","doi-asserted-by":"crossref","first-page":"455","DOI":"10.7326\/0003-4819-76-3-112-6-455","article-title":"Monoclonal immunoglobulin deposition disease: Light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis","volume":"112","author":"Buxbaum","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejca.2006.01.065_bib72","first-page":"45","article-title":"Primary systemic amyloidosis: clinical and laboratory features in 474 cases","volume":"32","author":"Kyle","year":"1995","journal-title":"Semin Hematol"},{"key":"10.1016\/j.ejca.2006.01.065_bib73","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1309\/LYWM47K2L8XYFFB3","article-title":"Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis","volume":"119","author":"Abraham","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ejca.2006.01.065_bib74","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1365-2141.2003.04433.x","article-title":"Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy","volume":"122","author":"Lachmann","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejca.2006.01.065_bib75","doi-asserted-by":"crossref","unstructured":"Guidelines on the diagnosis and management of AL amyloidosis. Br J Haematol 2004;125:681\u2013700.","DOI":"10.1111\/j.1365-2141.2004.04970.x"},{"key":"10.1016\/j.ejca.2006.01.065_bib76","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11864-002-0016-1","article-title":"Primary systemic amyloidosis","volume":"3","author":"Gertz","year":"2002","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.ejca.2006.01.065_bib77","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1182\/blood.V98.7.2266","article-title":"Translocations involving the immunoglobulin heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosis","volume":"98","author":"Hayman","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2006.01.065_bib78","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2141.2002.03438.x","article-title":"Translocations of 14q32 and deletions of 13q14 are common chromosomal abnormalities in systemic amyloidosis","volume":"117","author":"Harrison","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejca.2006.01.065_bib79","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/(SICI)1097-0142(19980415)82:8<1501::AID-CNCR11>3.0.CO;2-8","article-title":"Primary systemic amyloidosis with delayed progression to multiple myeloma","volume":"82","author":"Rajkumar","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2006.01.065_bib80","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM199709253371306","article-title":"The systemic amyloidosis","volume":"337","author":"Falk","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2006.01.065_bib81","first-page":"537A","article-title":"Amyloidosis and light chain deposition disease in renal biopsy specimens: Pathology, laboratory data, demographics and frequency (abstract)","volume":"8","author":"Harris","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejca.2006.01.065_bib82","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2141.1990.tb02539.x","article-title":"Relevance of class, molecular weight and isoelectric point in predicting human light amyloidogenicity","volume":"74","author":"Bellotti","year":"1990","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejca.2006.01.065_bib83","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood-2002-01-0114","article-title":"Analysis of V(lambda)-J(lambda) expression in plasma cells from primary (AL) amyloidosis and normal bone marrow identifies 3r (lambdaIII) as a new amyloid-associated germline gene segment","volume":"100","author":"Perfetti","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2006.01.065_bib84","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1056\/NEJM199008233230803","article-title":"Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component","volume":"323","author":"Hawkins","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2006.01.065_bib85","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood.V93.3.1062","article-title":"Long-term survival (10 years or more) in 30 patients with primary amyloidosis","volume":"93","author":"Kyle","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2006.01.065_bib86","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0272-6386(95)90647-9","article-title":"Treatment of amyloidosis","volume":"26","author":"Tan","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejca.2006.01.065_bib87","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1046\/j.1365-2141.1998.00772.x","article-title":"Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: A report on 21 patients","volume":"101","author":"Moreau","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejca.2006.01.065_bib88","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1182\/blood-2003-12-4192","article-title":"Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study","volume":"103","author":"Dispenzieri","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2006.01.065_bib89","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/sj.bmt.1704691","article-title":"Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate","volume":"34","author":"Gertz","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ejca.2006.01.065_bib90","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-140-2-200401200-00008","article-title":"High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: An 8-year study","volume":"140","author":"Skinner","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejca.2006.01.065_bib91","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.bmt.1704346","article-title":"High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial","volume":"33","author":"Sanchorawala","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ejca.2006.01.065_bib92","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1182\/blood-2004-01-0089","volume":"104","author":"Seldin","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2006.01.065_bib93","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1182\/blood-2004-05-1924","article-title":"Clinical efficacy of high-dose dexamethasone with maintenance dexamethasone\/alpha interferon in patients with primary systemic amyloidosis: results of United States Intergroup Trial Southwest Oncology Group (SWOG) S9628","volume":"104","author":"Dhodapkar","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2006.01.065_bib94","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3109\/13506120309041743","article-title":"Poor tolerance to high doses of thalidomide in patients with primary systemic amyloidosis","volume":"10","author":"Dispenzieri","year":"2003","journal-title":"Amyloid"},{"key":"10.1016\/j.ejca.2006.01.065_bib95","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1182\/blood-2004-08-3231","article-title":"The combination of thalidomide and intermediate-dose dexamethasone is an effective but toxic treatment for patients with primary amyloidosis (AL)","volume":"105","author":"Palladini","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2006.01.065_bib96","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1182\/blood-2002-06-1698","article-title":"Circulating peripheral blood plasma cells as a prognostic indicator in patients with primary systemic amyloidosis","volume":"101","author":"Pardanani","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2006.01.065_bib97","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/S0140-6736(03)13396-X","volume":"361","author":"Dispenzieri","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2006.01.065_bib98","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1161\/01.CIR.0000068314.02595.B2","volume":"107","author":"Palladini","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ejca.2006.01.065_bib99","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1182\/blood-2004-01-0390","article-title":"Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation","volume":"104","author":"Dispenzieri","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2006.01.065_bib100","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1182\/blood-2005-02-0691","article-title":"Clinical factors predictive of outcome with bortezomib in patients with relapsed, refractory multiple myeloma","volume":"106","author":"Richardson","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2006.01.065_bib101","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1200\/JCO.2004.05.984","article-title":"Immunomodulatory analogs of thalidomide: an emerging new therapy in myeloma","volume":"22","author":"Richardson","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2006.01.065_bib102","first-page":"363","article-title":"Multiple Myeloma","volume":"13","author":"Sirohi","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2006.01.065_bib103","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMra041875","article-title":"Multiple myeloma","volume":"351","author":"Kyle","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2006.01.065_bib104","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1056\/NEJM198006123022405","article-title":"Smoldering multiple myeloma","volume":"302","author":"Kyle","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2006.01.065_bib105","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1600-0609.1993.tb00148.x","article-title":"Initial versus deferred melphalan-prednisone therapy for asymptomatic multiple myeloma stage I \u2013 A randomized study: Myeloma Group of Western Sweden","volume":"50","author":"Hjorth","year":"1993","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ejca.2006.01.065_bib106","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/jncimonographs\/lgh039","article-title":"Cancer outcomes research","volume":"33","author":"Lipscombe","year":"2004","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"33","key":"10.1016\/j.ejca.2006.01.065_bib107","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/jncimonographs\/lgh017","article-title":"Taking stock of health related quality of life measurement in oncology practice in the United States","author":"Donaldson","year":"2004","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.ejca.2006.01.065_bib108","unstructured":"Tunis S, Stryer D, The outcomes of outcomes research at AHCRP. Publication no. AHCRP 99-R044 1999. Available from: http:\/\/www.AHRQ.gov\/clinic\/out2res."},{"key":"10.1016\/j.ejca.2006.01.065_bib109","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/sj.bmt.1700917","article-title":"Outcome assessment of a population-based group of 195 unselected myeloma patients under 70 years of age offered intensive treatment","volume":"20","author":"Powles","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ejca.2006.01.065_bib110","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1365-2141.2004.05340.x","article-title":"Less than half of patients aged 65 years or under with myeloma proceed to transplantation: results of a two region population-based survey","volume":"128","author":"Morris","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejca.2006.01.065_bib111","first-page":"7","article-title":"Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study Group","volume":"95","author":"Lenhoff","year":"2000","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ejca.2006.01.065_bib112","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1046\/j.0902-4441.2003.00195.x","article-title":"Interpretation of quality of life scores in multiple myeloma by comparison with a reference population and assessment of the clinical importance of score differences","volume":"72","author":"Gulbrandsen","year":"2004","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ejca.2006.01.065_bib113","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1046\/j.1365-2141.1999.01206.x","article-title":"Development of an EORTC questionnaire module to be used in health-related quality-of-life assessment for patients with multiple myeloma. European Organization for Research and Treatment of Cancer Study Group on Quality of Life","volume":"104","author":"Stead","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejca.2006.01.065_bib114","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1600-0609.2005.00509.x","article-title":"Quality of life may be affected more by disease parameters and response to therapy than by haemoglobin changes","volume":"75","author":"Wisloff","year":"2005","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ejca.2006.01.065_bib115","first-page":"319","article-title":"A progress report on the Medical Research Council\u2019s therapeutic trial in myelomatosis","volume":"15","author":"Galton","year":"1968","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejca.2006.01.065_bib116","first-page":"3832","article-title":"Combination of chemotherapy versus melphalan plus presnisolone as treatment for multiple myeloma: an overview of 6633 patients from 27 randomised trials","volume":"16","author":"Myeloma Trialists Collaborative Group","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2006.01.065_bib117","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/sj.thj.6200326","article-title":"Pulsed cyclophosphamide, thalidomide and dexamethasone: an oral regimen for previously treated patients with multiple myeloma","volume":"5","author":"Dimopoulos","year":"2004","journal-title":"Hematol J"},{"key":"10.1016\/j.ejca.2006.01.065_bib118","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0140-6736(92)90004-M","article-title":"Combined chemotherapy with ABCM versus melphalan for treatment of myelomatosis. The Medical Research Council Working Party for Leukaemia in Adults","volume":"339","author":"MacLennan","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2006.01.065_bib119","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199607113350204","article-title":"Prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma","volume":"355","author":"Attal","year":"1996","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ejca.2006.01.065_bib120","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1182\/blood.V93.1.55","article-title":"Total therapy with tandem transplants for newly diagnosed multiple myeloma","volume":"93","author":"Barlogie","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2006.01.065_bib121","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1056\/NEJMoa022340","article-title":"High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma","volume":"348","author":"Child","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2006.01.065_bib122","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMoa032290","article-title":"Single versus double autologous stem-cell transplantation for multiple myeloma","volume":"349","author":"Attal","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2006.01.065_bib123","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1182\/blood-2002-03-0889","article-title":"Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 studies","volume":"101","author":"Segeren","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2006.01.065_bib124","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/sj.bmt.1705000","article-title":"An elective single autograft with high-dose melphalan: single-center study of 451 patients","volume":"36","author":"Sirohi","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ejca.2006.01.065_bib125","doi-asserted-by":"crossref","unstructured":"Moreau P, Hullin C, Garban F, et al. Tandem autologous stem cell transplantation in high-risk de novo multiple myeloma: final results of the prospective and randomized IFM 99-04 protocol. Blood 2005 [Sept 13, Epub ahead of print].","DOI":"10.1182\/blood-2005-06-2573"},{"key":"10.1016\/j.ejca.2006.01.065_bib126","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0037-1963(01)90012-5","article-title":"Some early phase II trials in previously untreated multiple myeloma: The Royal Marsden Experience","volume":"38","author":"Sirohi","year":"2001","journal-title":"Semin Hematol"},{"key":"10.1016\/j.ejca.2006.01.065_bib127","first-page":"400a","article-title":"10-year Survival in Myeloma: A New Endpoint for Testing Potentially Curative Strategies?","volume":"100","author":"Powles","year":"2002","journal-title":"Blood"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804906005466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804906005466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T15:37:16Z","timestamp":1707147436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804906005466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":127,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0959804906005466"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2006.01.065","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}